Press Releases Intervacc AB

Equities

IVACC

SE0009607252

Market Closed - Nasdaq Stockholm Other stock markets 11:29:32 2024-04-26 EDT			5-day change	1st Jan Change
4.175 ^SEK	+3.34%		+0.85%	-34.04%

03-04	Intervacc AB Announces Changes in the Nomination Committee	CI
02-28	Intervacc's Acting CEO Assumes Role Permanently	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Notice of Annual General Meeting in Intervacc AB (publ)	04-15	AQ
Intervacc publishes the 2023 Annual Report	04-10	AQ
Intervacc announces changes in the Nomination Committee	03-04	AQ
Jonas Sohlman appointed as new CEO for Intervacc	02-28	AQ
Intervacc announces changes in dates for AGM and report for the first quarter 2024	02-22	AQ
Year-end report January - December 2023	02-16	AQ
Invitation to conference call and audiocast in connection with the year-end report	02-13	AQ
Intervacc awarded prestigious Eurostars grant to advance their new prototype vaccine against Streptococcus suis infection in pigs	02-07	AQ
Intervacc announces changes in the Nomination Committee	12-21	AQ
The National Equestrian Centre at Flyinge to host European expert meeting on the use of vaccination to prevent strangles in horses	12-11	AQ
Report from Extraordinary General Meeting in Intervacc	11-23	AQ
U.S. patent approval for Intervacc's vaccine against infections caused by Streptococcus suis	11-22	AQ
Interim report January - September 2023	11-16	AQ
Invitation to conference call with presentation of Intervacc's Interim report for the third quarter, 2023	11-15	AQ
Nomination Committee appointed in Intervacc	23-10-30	AQ
NOTICE OF EXTRAORDINARY GENERAL MEETING IN INTERVACC AB (PUBL)	23-10-19	AQ
Intervacc : Agneta Gustafsson joins Intervacc	23-09-12	PU
Andreas Andersson steps down as President and CEO. Jonas Sohlman has been appointed acting President and CEO for Intervacc	23-08-21	AQ
Intervacc awarded grant to optimise production processes for a fusion protein, which is one component of a prototype vaccine for pigs	23-08-17	AQ
Intervacc to collaborate with Testa Center to optimise production processes for their prototype vaccine for pigs	23-07-11	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Intervacc AB

Equities

IVACC

SE0009607252

Press Releases

Filters